금융 뉴스 허브

Cboe (CBOE) Is Up 12.1% After Extending S&P 500 Options License And Unveiling KPI Binaries

Cboe Global Markets and S&P Dow Jones Indices recently extended their exclusive licensing agreement for S&P 500 Index options through 2051, while Cboe also outlined plans to launch SEC-regulated binar ...

Beyond S&P 500 Index Funds: Here's the 1 Sector I'd Buy First as a New Investor

Buying entire baskets of stocks still makes for smart, instant diversification. But don't look past an obvious opportunity by insisting that only marketwide diversification is beneficial.

Warren Buffett Bought These 4 Dividend Stocks Years Ago. Here's What $1,000 in Each Would Be Worth Today.

American Express and Coca-Cola turned into big winners thanks to Buffett's buy-and-hold approach; Bank of America and Chevron could be next.

Stock Futures Kick Off New Week Ahead of Bank Reports

All three major stock indexes ended last week higher as a relentless bull market driven by AI spending enters its fourth year.

Wells Fargo, Bank of America, Domino’s, Johnson & Johnson, Inflation Data, and More to Watch This Week

Big bank earnings arrive, with Citi, Goldman Sachs, JPMorgan Chase, and more reporting. Consumer and producer price indexes and existing home sales data will provide a read on the economy.

‘Other Mommy’ tops weekend box office with $27M, domestic ticket sales cross $8B

Constellation’s $4.3 Billion Nuclear Upgrade Could Be Its Smartest Move Yet

Constellation Energy Corporation (NASDAQ:CEG) shares surged 12.2% on October 6, among the S&P 500’s biggest gains that day. The jump followed a 20-year deal with Google to add 890 megawatts of new nuc ...

How to Beat a Choppy Market With 4 Steady Stocks

These companies have proven to be safe havens during choppier markets.

Roche's experimental eye drug shows vision improvements in trials

The S&P 500 Just Hit a Record High -- Here's How Much Higher It Can Climb, According to the Wall Street Consensus

Analysts see another big year in the stock market. Here's what's behind the number.

Global equities mixed amid rising yields and oil prices

Merck's experimental eye drug meets goal in trial, but raises safety concerns